Showing 1 - 10 of 151
Beginning in 2003, Turkey initiated a series of reforms under the Health Transformation Program (HTP) that over the past decade have led to the achievement of universal health coverage (UHC). The progress of Turkey?s health system has few ? if any ? parallels in scope and speed. Before the...
Persistent link: https://www.econbiz.de/10011212023
Beginning in 2003, Turkey initiated a series of reforms under the Health Transformation Program (HTP) that over the past decade have led to the achievement of universal health coverage (UHC). The progress of Turkey?s health system has few, if any, parallels in scope and speed. Before the...
Persistent link: https://www.econbiz.de/10010937832
Persistent link: https://www.econbiz.de/10008527153
%), written information (90%) and the pharmacist (78%). There were a total of 299 constructs generated by 88 of the consumers and … pharmacist have good knowledge (median score 1) and are trained (median score 1) and were perceived to be trustworthy (median …
Persistent link: https://www.econbiz.de/10009448492
moderating roles of the appropriateness of the medication order and the relative expert power of the pharmacist. …
Persistent link: https://www.econbiz.de/10011263510
disciplines. An emphasis can be placed on interprofessional relationship that exists among the disciplines of psychiatry, pharmacy … that can be reaped from the involvement of psychiatry, pharmacy, and psychology in providing a focused and integrated …
Persistent link: https://www.econbiz.de/10011118337
To undertake a review of peer-reviewed literature to explore factors affecting pharmacists’ performance.
Persistent link: https://www.econbiz.de/10010577010
When entering the market, orphan drugs are associated with substantial prices and a high degree of uncertainty regarding safety and effectiveness. This makes decision making about the reimbursement of these drugs a complex exercise. To advance on this, the Dutch government introduced a...
Persistent link: https://www.econbiz.de/10011190139
Considerations beyond cost-effectiveness are important in reimbursement decision making. We assessed the importance of disease severity in drug reimbursement decision making in Belgium, France, The Netherlands and Sweden. We investigated scientific literature and policy documents and conducted...
Persistent link: https://www.econbiz.de/10011190143
The aim of this study was to analyze influences of process- and technology-related characteristics on the outcomes of coverage decisions. Using survey data on 77 decisions from 13 countries, we examined whether outcomes differ by 14 variables that describe components of decision-making processes...
Persistent link: https://www.econbiz.de/10011048364